PH15056A - Imidazole derivatives,compositions containing same and method of use - Google Patents

Imidazole derivatives,compositions containing same and method of use

Info

Publication number
PH15056A
PH15056A PH23412A PH23412A PH15056A PH 15056 A PH15056 A PH 15056A PH 23412 A PH23412 A PH 23412A PH 23412 A PH23412 A PH 23412A PH 15056 A PH15056 A PH 15056A
Authority
PH
Philippines
Prior art keywords
compositions containing
imidazole derivatives
containing same
imidazole
derivatives
Prior art date
Application number
PH23412A
Other languages
English (en)
Inventor
Peter Edward Cross
Roger Peter Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH15056(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of PH15056A publication Critical patent/PH15056A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH23412A 1978-12-13 1979-12-13 Imidazole derivatives,compositions containing same and method of use PH15056A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (1)

Publication Number Publication Date
PH15056A true PH15056A (en) 1982-06-03

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23412A PH15056A (en) 1978-12-13 1979-12-13 Imidazole derivatives,compositions containing same and method of use

Country Status (34)

Country Link
US (2) US4602016A (de)
JP (1) JPS585197B2 (de)
KR (1) KR830001243B1 (de)
AR (1) AR227637A1 (de)
AT (1) AT373879B (de)
AU (1) AU517892B2 (de)
BE (1) BE880584A (de)
CA (1) CA1108137A (de)
CH (1) CH644597A5 (de)
CS (1) CS216517B2 (de)
DD (1) DD147943A5 (de)
DE (1) DE2950019A1 (de)
DK (1) DK471479A (de)
EG (1) EG14227A (de)
ES (1) ES8101556A1 (de)
FI (1) FI70888C (de)
FR (1) FR2444031A1 (de)
GB (1) GB2038821B (de)
GR (1) GR73003B (de)
HU (1) HU183016B (de)
IE (1) IE49318B1 (de)
IL (1) IL58917A (de)
IT (1) IT1194900B (de)
LU (1) LU81985A1 (de)
NL (1) NL177749C (de)
NO (1) NO153135C (de)
NZ (1) NZ192360A (de)
PH (1) PH15056A (de)
PL (1) PL134005B1 (de)
PT (1) PT70571A (de)
SE (1) SE444937B (de)
SU (1) SU878195A3 (de)
YU (1) YU301879A (de)
ZA (1) ZA796708B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES539074A0 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
JPH0625141B2 (ja) * 1985-01-16 1994-04-06 三共株式会社 イミダゾ−ル誘導体およびその製法
KR920002129B1 (ko) 1986-01-27 1992-03-12 상꾜 가부시끼가이샤 티아나프텐 유도체의 제조방법
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
WO1995029165A2 (en) * 1994-04-26 1995-11-02 Syntex (U.S.A.) Inc. Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2003244913A1 (en) * 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
EP1660076A1 (de) * 2003-08-07 2006-05-31 B.M.R.A. Corporation B.V. Verfahren und zusammensetzungen enthaltend einen thromboxan-a2 antagonist und einen cox-1 inhibitor
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
US20110015158A1 (en) 2007-12-11 2011-01-20 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
SG11201408284VA (en) * 2012-05-22 2015-02-27 Xenon Pharmaceuticals Inc N-substituted benzamides and their use in the treatment of pain
BR112015008987A2 (pt) 2012-10-26 2017-07-04 Merck Sharp & Dohme composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
EP4538258A4 (de) * 2022-06-13 2025-07-30 Hefei Inst Of Pharmaceutical Industry Co Ltd Imidazolidinylvanillinsäureetherderivat und verwendung davon
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
NL177749C (nl) 1985-11-18
FI70888C (fi) 1986-10-27
SU878195A3 (ru) 1981-10-30
US4602016A (en) 1986-07-22
US4636500A (en) 1987-01-13
SE7910204L (sv) 1980-06-14
FI793868A7 (fi) 1980-06-14
JPS585197B2 (ja) 1983-01-29
ZA796708B (en) 1981-08-26
IL58917A (en) 1984-03-30
JPS5585572A (en) 1980-06-27
AR227637A1 (es) 1982-11-30
HU183016B (en) 1984-04-28
CH644597A5 (de) 1984-08-15
CS216517B2 (en) 1982-11-26
LU81985A1 (fr) 1980-04-22
YU301879A (en) 1983-01-21
NZ192360A (en) 1982-02-23
KR830001243B1 (ko) 1983-06-27
DE2950019A1 (de) 1980-07-10
AU517892B2 (en) 1981-09-03
KR830001242A (ko) 1983-04-29
FR2444031A1 (fr) 1980-07-11
IE49318B1 (en) 1985-09-18
FI70888B (fi) 1986-07-18
PT70571A (en) 1980-01-01
IE792403L (en) 1980-06-13
GB2038821A (en) 1980-07-30
GR73003B (de) 1984-01-24
EG14227A (en) 1983-12-31
ATA783379A (de) 1983-07-15
DD147943A5 (de) 1981-04-29
PL134005B1 (en) 1985-07-31
PL220351A1 (de) 1980-12-01
ES486782A0 (es) 1980-12-16
AT373879B (de) 1984-02-27
CA1108137A (en) 1981-09-01
NL177749B (nl) 1985-06-17
GB2038821B (en) 1982-12-08
NO153135C (no) 1986-01-22
AU5372579A (en) 1980-06-19
IT1194900B (it) 1988-09-28
ES8101556A1 (es) 1980-12-16
BE880584A (fr) 1980-06-12
NL7908899A (nl) 1980-06-17
IT7941669A0 (it) 1979-12-11
IL58917A0 (en) 1980-03-31
NO153135B (no) 1985-10-14
FR2444031B1 (de) 1983-06-10
SE444937B (sv) 1986-05-20
NO794069L (no) 1980-06-16
DK471479A (da) 1980-06-14

Similar Documents

Publication Publication Date Title
PH15056A (en) Imidazole derivatives,compositions containing same and method of use
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
IL56556A0 (en) Imidazole derivatives and salts thereof and pharmaceuticalcompositions containing them
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
PH17937A (en) Imidazole derivatives,their compositions and use thereof
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
PH14401A (en) Hydroxyaminohydrocarbonphosphonic acid derivatives,compositions containing same and method of use
GB2017681B (en) Derivatives of 3-phenyl-3-phenoxy-propanamine
IL57849A (en) Imidazole derivatives and pharmaceutical compositions containing same
PH14356A (en) Derivatives of penicillanic acid,compositions containing same and method of use
IL57040A (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
DE2963228D1 (en) Urea derivatives, processes for preparing them and compositions containing them
GB2019840A (en) Bis-anthranilates of urea derivatives
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
PH18500A (en) Method compounds and compositions containing them
PH19347A (en) Triazole derivatives,pharmaceutical composition containing same and method of use thereof
PH13728A (en) Chromene derivatives,compositions containing same and their method of use
GB2025422B (en) 17-acetylene derivatives of androst-4-ene
GB2104524B (en) Derivatives of 1a, 25-dihydroxycholesterol
JPS5519272A (en) Imidazoline derivative and medical composition
CU35135A (en) Derivatives of dichlohexadiene
PH14835A (en) Isoquinoline derivatives,their composition and method of use
IL57436A0 (en) Hydantoin derivatives and pharmaceutical compositions containing them
PH16128A (en) Benzodiazepine derivatives,their pharmaceutical composition and method of use
NZ190952A (en) Imidazole and triazole derivatives and fugicidal compositions